Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543594 | NSE Symbol : | ISIN : INE0MC401013 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
03-May-2025	03-May-2025	Change in Other Executives	Kindly find the attached outcome of the Board Meeting held today i.e. 3rd May, 2025
07-Mar-2025	12-Mar-2025	Preferential Issue	Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/03/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 12th March 2025 at 03:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss consider and approve inter-alia: 1.The draft Valuation Report for issue of Convertible warrants on preferential basis. 2.The notice convening Extra- Ordinary General Meeting of the Company. 3.Any other agenda/ business matter to be discussed with the permission of Chairperson of the Board Meeting. Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Wednesday, 12th March, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 03:00 P.M. and concluded at 05:00 P.M. inter-alia has: 1. Considered and approved Valuation Report issued by Mr. Manish Santosh Buchasia, Registered Valuer, Ahmedabad, in accordance with Regulation 164 of SEBI (ICDR) Regulation, 2018. 2. Decided to hold Extra-Ordinary General Meeting ('EGM') of the shareholders of the Company on Friday, 4th April, 2025 at 03:00 P.M. through Video Conferences ('VC') / Other Audio-Visual Means ('OAVM'). (As Per BSE Announcement dated on 12.03.2025)
11-Feb-2025	24-Feb-2025	Preferential Issue	Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/02/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday 24th February 2025 at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss and consider inter-alia: 1. Proposal of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis. 2. Any other agenda/ business matter to be discuss with the permission of Chairperson of the Board Meeting. Kindly take the same on your record and oblige us. Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Monday, 24th February, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 04:00 P.M. and concluded at 04:30 P.M. inter-alia has, considered and approved 1. Raising of funds upto Rs. 99.99 Crores (Rupees Ninety-Nine Crores and Ninety-Nine Lakhs Only) by way of issue of Warrants (hereinafter referred to as 'Convertible Warrants'), through preferential allotment to the person(s)/ entity(ies) belonging to 'Promoter and Promoter Group Category' and 'Non-Promoter category', as per Chapter V of SEBI (ICDR) Regulations, 2018, subject to approval of Shareholders and other authorities concerned (As per BSE Announcement Dated on 24/02/2025)
30-Jan-2025	06-Feb-2025	Preferential Issue	Preferential Issue of shares & Issue Of Warrants Pursuant to the Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. Thursday, 6th February, 2025 which commenced at 03:00 P.M. and concluded at 03:20 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, Gujarat, Board of Directors has decided not to proceed with the agenda of raising of funds by way of issue of Equity shares and/ or Warrants on Preferential basis. (As Per BSE Announcement Dated on: 06/02/2025)
11-Dec-2024	11-Dec-2024	Half Yearly Results	Outcome of Board Meeting held today i.e. 11th December, 2024
11-Oct-2024	11-Oct-2024	Change in Directors	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 11th October, 2024 at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055 which commenced at 5:30 P. M. and concluded at 7:00 P.M. inter-alia has, considered and approved appointment of Mr. Nirav Soni (DIN: 08317653) as Additional Non-Executive and Non-Independent Director of the Company w.e.f. 11th October, 2024. The details required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09/09/2015 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated 11/07/2023 are given in Annexure A. Kindly take the same on your record and oblige us
18-Sep-2024	18-Sep-2024	Stock Split	Pursuant to the Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e., Wednesday, 18th September, 2024 which commenced at 05:00 P.M. and concluded at 05:30 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, Gujarat, has decided to withdraw the Split/ Sub-division of Equity Shares of the Company from face value of Rs. 10/- each to face value of Re. 1/- each, which was approved by Shareholders in the Annual General Meeting held on 27th August, 2024. Kindly note that, the face value of Equity share of the Company will be Rs. 10/- (Rupees Ten Only).
24-Jul-2024	29-Jul-2024	Preferential Issue	Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday 29th July 2024 at 03:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss and consider agenda mentioned in the Intimation. Pursuant to the Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. Monday, 29th July, 2024 which commenced at 03:00 P.M. and concluded at 06:30 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, Gujarat, inter-alia considered and approved agenda''s mentioned in the attached outcome. (As Per BSE Announcement Dated on: 29/07/2024)
10-Jun-2024	12-Jun-2024	Accounts	Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 12th June 2024 at 3:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India - 380 055 inter-alia to consider and approve the Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2024 along with Auditor Report. Pursuant to Regulations 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 12th June, 2024, at the registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380055, which commenced at 3:00 P.M. and concluded at 9:40 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report. (As Per BSE Announcement Dated on: 12/06/2024)
08-Apr-2024	06-May-2024	Bonus Issue	Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Friday 26th April 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss and consider inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Friday, 26th April, 2024 at 2:00 P.M., is now rescheduled to Thursday, 2nd May, 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. 3. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. (As Per BSE Announcement Dated on: 25/04/2024) Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May, 2024 Pursuant to the second proviso to Regulation 30(6) of the SEBI (LODR) Regulations, 2015, we hereby inform you the Board of Directors of the Company meeting held today i.e. Thursday, 2nd May, 2024 which commenced at 2:00 P.M., and Concluded at 7:30 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, has decided to Re-schedule the meeting to be held on 6th May, 2024 for discuss and consider, inter-alia: The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. The proposal of sub-division of equity shares of the Company. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. Note that meeting is reschedule due to requirement of expert advice. (As Per BSE Announcement Dated on 02.05.2024) Outcome of Board Meeting held on 6th May, 2024 (As per BSE Announcement Dated on 06/05/2024)
29-Mar-2024	28-Mar-2024	Right Issue	Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 ('the Regulations'), we hereby inform you that the Rights Issue Committee of Directors of the Company in their meeting held on Thursday, 28th March, 2024 at the Registered Of??ice of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, which commenced at 4:00 P.M. and concluded at 6:00 P.M. inter-alia had considered and approved as per attachment. Read less..
19-Mar-2024	19-Mar-2024	Right Issue	With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 19th March, 2024 the date of closure of the captioned Right Issue, which had opened on Monday, 26th February, 2024 and scheduled to close on Tuesday, 19th March, 2024 has now been extended by the Company from Tuesday, 19th March, 2024 to Wednesday, 20th March, 2024 in order to provide an opportunity to shareholders to exercise their rights in the Rights Issue. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 03:00 P.M.
15-Mar-2024	15-Mar-2024	Right Issue	With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 15th March, 2024 the date of closure of the captioned Right Issue, which had opened on Monday, 26th February, 2024 and scheduled to close on Friday, 15th March, 2024 has now been extended by the Company from Friday, 15th March, 2024 to Tuesday, 19th March, 2024 in order to provide an opportunity to shareholders to exercise their rights in the Rights Issue. The meeting of the Board of Directors commenced at 10:00 A.M. and concluded at 11:00 A.M. Read less.
06-Mar-2024	06-Mar-2024	Right Issue	Extension of issue closing date of Rights Issue from 07/03/2024 to 15/03/2024.
31-Jan-2024	31-Jan-2024	Right Issue	Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in consultation with the Rights Issue Committee in their meeting held today i.e. 31st January, 2024 at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, which commenced at 5:00 P.M. and concluded at 7:00 P.M. inter-alia has considered and approved issue upto 1,29,67,500 Equity Shares of face value of Rs. 10.00/- each for cash at an Issue Price of Rs. 10.00/- per Equity Share aggregating upto Rs. 12,96,75,000/- to all the existing eligible Equity shareholders of the Company on Rights ('Rights Issue'). The brief term of Rights Issue is approved by the Board is attached herewith as Annexure - I.

1 2

LOGIN HERE

Dipna Pharmachem Ltd

Board Meeting